Steven Oliveira

Presidente presso Oliveira Capital LLC

Patrimonio netto: 343 569 $ in data 31/05/2024

56 anni

Health Technology

Consumer Durables

Miscellaneous

Posizioni attive di Steven Oliveira

Società	Posizione	Inizio	Fine
Oliveira Capital LLC	Presidente	01/01/2002	-

Società	Posizione	Inizio	Fine
Chardan SPAC Asset Management LLC	Direttore degli Investimenti	01/01/2008	01/01/2013
IDEANOMICS, INC.	Direttore/Membro del Consiglio	30/11/2010	30/03/2011
REPROS THERAPEUTICS INC	Direttore/Membro del Consiglio	11/10/2011	-
SIGA TECHNOLOGIES, INC.	Fondatore	01/01/1995	-
CSO Ventures	Corporate Officer/Principal	01/01/1995	-
Assertio Therapeutics, Inc. Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.	Fondatore	-	-
Pulte Acquisition Corp. Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL.	Direttore/Membro del Consiglio	30/07/2015	-
	Independent Dir/Board Member	30/07/2015	-

Manhattan College

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Director/Board Member	3
Founder	2
Independent Dir/Board Member	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
IDEANOMICS, INC.	Consumer Durables
SIGA TECHNOLOGIES, INC.	Health Technology

Aziende private	6
Pulte Acquisition Corp. Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL.	Miscellaneous
Oliveira Capital LLC
Chardan SPAC Asset Management LLC
Assertio Therapeutics, Inc. Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.	Health Technology
CSO Ventures
Repros Therapeutics, Inc. Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX.	Health Technology